Carl‐fredrik Flach - Infectious Diseases

Author Information

Carl-Fredrik Flach is a prominent researcher affiliated with the Centre for Antibiotic Resistance Research (CARe) at the University of Gothenburg, as well as the Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, in Gothenburg, Sweden. His work focuses on the critical field of antibiotic resistance, and he has contributed extensively to understanding the environmental and public health aspects of microbial resistance.

Research Contributions

Carl-Fredrik Flach has made significant contributions to the study of antibiotic resistance, particularly in the context of wastewater treatment and its implications for public health. His research includes examining the impact of international travel on the spread of resistant bacteria, such as extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, and the role of wastewater as a vector for antibiotic resistance genes. Notably, his work with the AWARE Study highlights the risks posed by wastewater to workers and residents, emphasizing the importance of wastewater-based epidemiology in monitoring and managing antibiotic resistance.

Aliases

The author is also known by the aliases C.-f. Flach and Carl–fredrik Flach.

Publication and Citation Metrics

Total Papers	73
Citation Count	3500
H-index	32

Publications:

International travel as a risk factor for carriage of extended-spectrum Î²-lactamase-producing Escherichia coli in a large sample of European individuals - The AWARE Study

DOI: 10.1101/2022.03.11.22272258

Year: 2022

International Travel as a Risk Factor for Carriage of Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Large Sample of European Individuals—The AWARE Study

DOI: 10.3390/ijerph19084758

Year: 2022

Long-read metagenomic sequencing reveals shifts in associations of antibiotic resistance genes with mobile genetic elements from sewage to activated sludge

DOI: 10.1186/s40168-021-01216-5

Year: 2022

Antibiotic Resistance in Wastewater Treatment Plants and Transmission Risks for Employees and Residents: The Concept of the AWARE Study

DOI: 10.1101/2021.02.03.21250668

Year: 2021

Wastewater Based Epidemiology Enabled Surveillance of Antibiotic Resistance

DOI: 10.1101/2021.06.01.21258164

Year: 2021

Carriage of ESBL-producing Enterobacterales in wastewater treatment plant workers and surrounding residents — the AWARE Study

DOI: 10.1007/s10096-021-04387-z

Year: 2021

Investigating the effects of municipal and hospital wastewaters on horizontal gene transfer.

DOI: 10.1016/j.envpol.2021.116733

Year: 2021

Evidence for selection of multi-resistant E. coli by hospital effluent.

DOI: 10.1016/j.envint.2021.106436

Year: 2021

Antibiotic resistance genes of emerging concern in municipal and hospital wastewater from a major Swedish city.

DOI: 10.1016/j.scitotenv.2021.151433

Year: 2021

Antibiotic Resistance in Wastewater Treatment Plants and Transmission Risks for Employees and Residents: The Concept of the AWARE Study

DOI: 10.3390/antibiotics10050478

Year: 2021

What is the Immune Response?

When are Imaging Studies Recommended?

How Effective are Vaccines?

What are Antipyretics?

How Can HSV Be Prevented?

How Does the CDC Monitor Infectious Diseases?

What are the treatment options for HIV?

What are the Objectives of the RBM Partnership?

How is HSV Transmitted?

How Do Pathogens Evade the Immune System?

Partnered Content Networks

Relevant Topics